Follow
Ganesan Vaidyanathan
Ganesan Vaidyanathan
Duke University Medical Center
Verified email at duke.edu
Title
Cited by
Cited by
Year
A plasmonic gold nanostar theranostic probe for in vivo tumor imaging and photothermal therapy
Y Liu, JR Ashton, EJ Moding, H Yuan, JK Register, AM Fales, J Choi, ...
Theranostics 5 (9), 946, 2015
2572015
Astatine-211-labeled radiotherapeutics an emerging approach to targeted alpha-particle radiotherapy
MR Zalutsky, G Vaidyanathan
Current pharmaceutical design 6 (14), 1433-1455, 2000
2462000
Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F] fluorobenzoate
G Vaidyanathan, MR Zalutsky
International journal of radiation applications and instrumentation. Part B …, 1992
1981992
Synthesis of N-succinimidyl 4-[18F] fluorobenzoate, an agent for labeling proteins and peptides with 18F
G Vaidyanathan, MR Zalutsky
Nature protocols 1 (4), 1655-1661, 2006
1572006
Targeted α-particle radiotherapy with 211At-labeled monoclonal antibodies
MR Zalutsky, DA Reardon, OR Pozzi, G Vaidyanathan, DD Bigner
Nuclear medicine and biology 34 (7), 779-785, 2007
1402007
Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and …
CJ Reist, GE Archer, SN Kurpad, CJ Wikstrand, G Vaidyanathan, ...
Cancer research 55 (19), 4375-4382, 1995
1341995
Improved synthesis of N-succinimidyl 4-[18F] fluorobenzoate and its application to the labeling of a monoclonal antibody fragment
G Vaidyanathan, MR Zalutsky
Bioconjugate Chemistry 5 (4), 352-356, 1994
1311994
Targeted therapy using alpha emitters
G Vaidyanathan, MR Zalutsky
Physics in Medicine & Biology 41 (10), 1915, 1996
1211996
No-carrier-added synthesis of meta-[131I] iodobenzylguanidine
G Vaidyanathan, MR Zalutsky
Applied Radiation and Isotopes 44 (3), 621-628, 1993
1201993
(2S)-2-(3-(1-carboxy-5-(4-211At-astatobenzamido) pentyl) ureido)-pentanedioic acid for PSMA-targeted α-particle radiopharmaceutical therapy
AP Kiess, IL Minn, G Vaidyanathan, RF Hobbs, A Josefsson, C Shen, ...
Journal of Nuclear Medicine 57 (10), 1569-1575, 2016
1042016
Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody
M Pruszynski, E Koumarianou, G Vaidyanathan, H Revets, N Devoogdt, ...
Nuclear medicine and biology 40 (1), 52-59, 2013
952013
Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas
Y Kato, G Vaidyanathan, MK Kaneko, K Mishima, N Srivastava, ...
Nuclear medicine and biology 37 (7), 785-794, 2010
892010
Astatine radiopharmaceuticals: prospects and problems
G Vaidyanathan, MR Zalutsky
Current radiopharmaceuticals 1 (3), 177-196, 2008
812008
Fluorine-18-labeled [Nle4, D-Phe7]-α-MSH, an α-melanocyte stimulating hormone analogue
G Vaidyanathan, MR Zalutsky
Nuclear medicine and biology 24 (2), 171-178, 1997
811997
Uptake mechanisms of meta-[123I] iodobenzylguanidine in isolated rat heart
TR DeGrado, MR Zalutsky, G Vaidyanathan
Nuclear medicine and biology 22 (1), 1-12, 1995
811995
Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents
G Vaidyanathan, MR Zalutsky
Bioconjugate chemistry 1 (4), 269-273, 1990
801990
1-(meta-[211At] Astatobenzyl) guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation
G Vaidyanathan, MR Zalutsky
Bioconjugate chemistry 3 (6), 499-503, 1992
791992
Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling
M Pruszynski, E Koumarianou, G Vaidyanathan, H Revets, N Devoogdt, ...
Journal of nuclear medicine 55 (4), 650-656, 2014
772014
Applications of 211At and 223Ra in targeted alpha-particle radiotherapy
G Vaidyanathan, M R Zalutsky
Current radiopharmaceuticals 4 (4), 283-294, 2011
752011
Cytotoxicity of α-Particle-emitting m-[211At]Astatobenzylguanidine on Human Neuroblastoma Cells
DK Strickland, G Vaidyanathan, MR Zalutsky
Cancer research 54 (20), 5414-5419, 1994
741994
The system can't perform the operation now. Try again later.
Articles 1–20